1. Investment Snapshot

2. Thesis

3. Valuation & Price Target

4. Business & Product Moat

5. People & Governance

6. Market & Macro

7. Financial Quality

8. Risk Register

9. Prediction Market

10. 𝕏 Posts

Discussion

Eikon Therapeutics, Inc. (EIKN) IPO | IPOSignal

Sections

1. Investment Snapshot

2. Capital Structure

3. Valuation

Discussion

Inline comments

Investment Snapshot

Capital Structure

Valuation

Discussion

Eikon Therapeutics, Inc.

Analyst research, target price, syndicate analytics, and valuation sections are included with an active subscription. View plans

Investment Snapshot

424B4 All Filings

Symbol

EIKN

Event Date

2026-02-05

Sector

Health Care

Subsector

Biotechnology

Offer Range

—

Shares Offered

17.65M

Shares Outstanding Pre-IPO

2.95M

Total Shares Post-IPO

50.45M

Market Cap

—

Target Price

$00.00

Implied Upside vs Midpoint

$00.00

Description

—

Capital Structure

Post-IPO economic shares by class.

Class	Shares	% Economic
Common Stock (listed) 1 vote per share	50.45M	100.0%
Total economic shares	50.45M	100%

Not counted toward economic shares

Redeemable Convertible Preferred Stock (aggregate)

Pre-conversion — already in the listed class

222.66M

Valuation

████████████████████